41
Participants
Start Date
January 19, 2021
Primary Completion Date
August 20, 2024
Study Completion Date
November 18, 2024
Rimegepant
Active Agent
Placebo
Placebo Comparator
Weill Cornell Medicine, New York
Sadick Dermatology, New York
Collaborators (1)
Pfizer
INDUSTRY
Weill Medical College of Cornell University
OTHER